Latest News
Accelitech to Launch its 6th CyberKnife Program in Partnership with Saint Peter's University Hospital in New Brunswick, NJ
Chicago, IL, August 28, 2009 — Accelitech LLC, a leading developer of stereotactic radiosurgery programs, is pleased to announce the launch of its 6th new CyberKnife Center with Saint Peter’s University Hospital in New Brunswick, NJ. The new technology will be operated by Saint Peter’s as part of its cancer program, which is accredited by the American College of Surgeons. The CyberKnife is expected to be operational and available to serve the patients of central New Jersey by early 2010.
“The CyberKnife is an exciting new technology option, sometimes referred to as knifeless surgery, for our physicians to offer to their patients who are battling cancer,” said Al Glover, president and chief executive officer at Saint Peter’s University Hospital, a member of Saint Peter’s Healthcare System. “Enhancing tumor targeting allows for greater precision which translates into the safe delivery of higher doses of radiation therapy and the need for fewer patient treatments.”
“Despite these challenging economic times, it was essential for Saint Peter’s to obtain the latest in radiation therapy technology by bringing the CyberKnife to our market,” said Garrick Stoldt, chief financial officer at Saint Peter’s. “With the addition of the CyberKnife to our accredited cancer program, we’ve created the best cancer treatment program in the region.”
“Many hospitals like Saint Peter’s strive to build and grow leading cancer programs despite the financial challenges facing the healthcare system throughout the United States” said Scott Milligan, the chief development officer of Accelitech. “Our proven model allows hospital’s like Saint Peter’s to deliver new, competitive technology without the large capital outlay. We act in essence as the capital partner and safety net. With that, our business is experiencing a spike in demand as hospitals and health systems around the country wrestle with these very challenging and real issues.”
About Accelitech LLC
Accelitech LLC is a leading developer of stereotactic radiosurgery programs. Headquartered in Chicago, Accelitech offers broad experience and resources in healthcare law, finance, development, and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech currently has seven sites in addition to many projects under development throughout the United States.